You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Trastuzumab for the treatment of HER2-positive metastatic gastric cancer

  • Technology appraisal guidance
  • Reference number: TA208
  • Published:  24 November 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders Appendix A: provisional matrix of stakeholders
27 August 2013
(104.84 Kb 30 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 23 August 2013

Back to top